U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.
Source link
Related Posts
How the Crypto Industry’s Political Spending Is Paying Off
At the end of a three-hour hearing last month, Senator Ruben Gallego, Democrat of Arizona, sided with a group of Republicans in a hotly contested […]
Why Warren Buffett’s Departure from Berkshire Hathaway Matters
It was closing in on 1 p.m. here when Warren Buffett, seated onstage before a rapt audience of about 40,000 at the CHI Health Center, […]
U.S. Job Growth Remained Strong in April
A solid labor market has for months given the Federal Reserve comfort that it could hold off on interest rate cuts until it had more […]